Buyun Tang

Sanofi (France)

Papers

1

Total Citations

2

H-Index

1

About

Buyun Tang is a rising figure in laboratory automation and bioprocess optimization, with a focus on accelerating drug discovery workflows. Their key research areas include robotic process integration, high-throughput biochemical assays, and cycle time reduction in pharmaceutical development. Tang’s major contribution lies in demonstrating how modular robotic platforms can automate multiplex biochemical assays, enabling simultaneous acquisition of multiparameter data within a single run. This approach directly addresses the industry’s need to shorten the design–make–test–analyze (DMTA) cycle, a critical bottleneck in early-stage drug development. Their 2024 paper, “Automation of multiplex biochemical assays to enhance productivity and reduce cycle time using a modular robotic platform,” has already garnered early citations, signaling growing interest from both academic and industrial researchers. Tang’s work is notable for bridging the gap between automation engineering and practical pharmaceutical needs, offering a scalable solution that can be adapted across different assay types. As the push for faster, data-rich screening intensifies, Tang’s innovations are poised to become foundational in next-generation laboratory automation.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Automation of multiplex biochemical assays to enhance productivity and reduce cycle time using a modular robotic platform
2 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Sanofi (France)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago